Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Percutaneous Coronary Intervention: From the STOPDAPT-2 Total Cohort

BACKGROUND: The benefit of clopidogrel monotherapy after 1-month dual antiplatelet therapy (DAPT) compared with 12-month DAPT with aspirin and clopidogrel was demonstrated in the STOPDAPT-2 (Short and Optimal Duration of Dual Antiplatelet Therapy After Everolimus-Eluting Cobalt-Chromium Stent-2), bu...

Descripción completa

Detalles Bibliográficos
Autores principales: Obayashi, Yuki, Watanabe, Hirotoshi, Morimoto, Takeshi, Yamamoto, Ko, Natsuaki, Masahiro, Domei, Takenori, Yamaji, Kyohei, Suwa, Satoru, Isawa, Tsuyoshi, Watanabe, Hiroki, Yoshida, Ruka, Sakamoto, Hiroki, Akao, Masaharu, Hata, Yoshiki, Morishima, Itsuro, Tokuyama, Hideo, Yagi, Masahiro, Suzuki, Hiroshi, Wakabayashi, Kohei, Suematsu, Nobuhiro, Inada, Tsukasa, Tamura, Toshihiro, Okayama, Hideki, Abe, Mitsuru, Kawai, Kazuya, Nakao, Koichi, Ando, Kenji, Tanabe, Kengo, Ikari, Yuji, Morino, Yoshihiro, Kadota, Kazushige, Furukawa, Yutaka, Nakagawa, Yoshihisa, Kimura, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371064/
https://www.ncbi.nlm.nih.gov/pubmed/35912647
http://dx.doi.org/10.1161/CIRCINTERVENTIONS.122.012004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371064/
https://www.ncbi.nlm.nih.gov/pubmed/35912647
http://dx.doi.org/10.1161/CIRCINTERVENTIONS.122.012004

Ejemplares similares